BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 12, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 29, 2017
View Archived Issues
Shenzhen Targetrx Biotechnology divulges EGFR inhibitors
Read More
TP Therapeutics wins FDA orphan drug designation for lead clinical compound
Read More
New GPR40 agonist ID-11014A shows preclinical liver safety and effects on glucose tolerance
Read More
Bitopertin shows promise for treating beta-thalassemia-derived anemia
Read More
FDA gives orphan drug status to IDN-7314 from Conatus Pharmaceuticals
Read More
Mithra enters license and supply agreement with Fuji Pharma for Donesta
Read More
Global Blood Therapeutics' GBT-440 obtains EMA PRIME designation
Read More
Alma Bio and Delphi Genetics extend plasmid DNA drug alliance
Read More
Small-molecule SIK1 inhibitors for topical induction of UV-independent skin pigmentation
Read More
Scholar Rock announces plans to develop lead candidate to improve muscle function in SMA
Read More
Amicus Therapeutics applies for approval of migalastat in Japan
Read More
Opiant Pharmaceuticals licenses drug delivery technology from Aegis
Read More
EC grants orphan drug status to Catalyst Biosciences' CB-2679d
Read More
H3B-8800 named U.S. orphan drug for acute myeloid leukemia and chronic myelomonocytic leukemia
Read More
Sinovac Biotech enters definitive amalgamation agreement
Read More
Mateon Therapeutics reports preclinical data on CA4P
Read More
Chengdu Suncadia Pharmaceuticals and collaborator patent mu-opioid receptor antagonists
Read More
Auspherix discloses gold complexes as antibacterials
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group divulges elbasvir analogues
Read More
Patient enrollment begins in phase II trial of GKT-831 in primary biliary cholangitis
Read More
INVAC-1 vaccine safe and immunogenic in first-in-human study
Read More
European approval for Zykadia for first-line ALK-positive NSCLC
Read More
Minomic advances cancer imaging trial of miltuximab
Read More
Savolitinib begins phase III study in papillary renal cell carcinoma
Read More
Servier and Transgene partner on application of viral vectorization technology to allogenic CAR-T
Read More
Gemphire reports topline data on phase IIb study of gemcabene for HoFH
Read More
Bioverativ completes True North Therapeutics acquisition
Read More
Pharmaleads reports initial phase I data on PL-265 for neuropathic pain
Read More